A Study on the Protection of Hemodialysis Patients Against Diphtheria and Tetanus

Figures & data

Table 1  Comparison of age, gender, and tetanus and diphtheria antibody between patients and control groups

	Hemodialysis patients, mean values	Control group, mean values	p value
Age (year)	54.5 + 14.3	53.9 ± 14.2	p = 0.81
Gender	60 (53%) men, 52 (47%) women	14 (39%) men, 22 (61%) women	p = 0.18
Tetanus, IgG IU/ML	0.21± 0.46	0.57 ± 1.13	p = 0.08
Diphtheria, IgG IU/ML	0.38 ± 0.37	0.43 ± 0.44	p = 0.48

Figure 1. The patients and control groups were divided into protected and unprotected groups against tetanus and also diphtheria. Protection was defined as an antibody level of 0.1 IU/ML for tetanus and 1 IU/ML for diphtheria.

Table 2  Details of the patients group

	Age(year)	BMIKg/m2	Durationofdialysis(weeks)	Dialysis frequency time/week	ALBg/dL	Hbg/dL	VENO	EPO	Urea reduction ratio	KT/Vurea	Zincmg/L
Mean level	54.5 ± 14	23.1 ± 5	27.5 ± 31	2.1 ± 0.6	2.5 ± 0.9	9.3 ± 1.9	2.08 ± 2	4.73 ± 4	54% ± 7%	0.7 ± 0.17	84.3 + 26

*Erythropoietin or venofer injections per month.

Duration of dialysis is given in week and the number of dialysis is in time per week.

Abbreviations: Alb = albumin, Hb = hemoglobin.